Month: June 2025

Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025 Halle (Saale) / Munich, Germany, June 6, 2025 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and fibrotic disorders, with a primary focus on kidney diseases, today announced that meta-analysis data for its lead drug in development, varoglutamstat, was presented at the 62nd ERA Congress of the European Renal Association in Vienna, Austria, today, June 6, 2025. “We are delighted that the results of the Phase 2 program were accepted for presentation at the ERA 2025 congress. This allowed Vivoryon to share the outstanding improvements of varoglutamstat on kidney function (eGFR) with the scientific and medical expert community in the...

UAB “Kvartalas” aimed to raise 5 million euros during the offering of the third tranche of bonds to finance the development of the “Sąvaržėlė” business centre on Konstitucijos ave. in Vilnius. The offering began on June 3 and was initially scheduled to run until June 13. However, considering the high demand for Bonds in the previous tranches, in this tranche, the Issuer had the right to shorten the offering period once it determined that sufficient investor demand has been reached, to ensure higher allocation to investors. The offering was completed on the third day (June 5), having reached 11.5 million euros in demand at nominal value – more than double the amount initially offered. The Issuer appreciates the continued trust shown by investors and their active participation from the first days of the offering....

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) (4174. TWO), and TegMine Therapeutics, Inc. (TegMine), a US Biopharma specialized in developing best-in-class antibodies targeting cancer glycans and glycoproteins, have entered into an ADC-related Master Services Agreement (MSA). Under the terms of the MSA, OBI grants TegMine rights to utilize OBI’s GlycOBI® ADC enabling technologies, powered by EndoSymeOBI® and HYPrOBI®, to identify ADC therapeutics candidates for potential clinical development. If an ADC product candidate(s) is ensued, OBI and TegMine would enter into a formal licensing agreement. “This strategic collaboration leverages the synergistic strengths of both...

(2025-06-06) Kitron has signed a significant manufacturing agreement with a leading customer in the industrial automation sector. The agreement covers electronics manufacturing services for a new generation of high-performance drive modules used in automation and motion control systems. Valued at approximately EUR 7 million annually, the contract represents a strategic expansion of the partnership, with room for further volume growth in the years ahead. Under the agreement, Kitron will provide complete box-build services from its European facilities, delivering high-quality, high-complexity assemblies tailored to demanding industrial environments. Production is scheduled to begin in the fourth quarter of 2025. “Our ability to meet stringent requirements of advanced automation systems has been crucial in this win,” said Mindaugas Sestokas,...

Press Release no. 03/2025 Kenyan government has revealed plans to adopt the Danish F2 platformCopenhagen, June 6, 2025cBrain (NASDAQ: CBRAIN) is pleased to share that the Kenyan Ministry of Information, Communications, and the Digital Economy has revealed plans to roll out the F2 digital platform across all government departments, thereby transitioning into paperless working environments. The plans were shared with Kenyan media by Cabinet Secretary William Kabogo on June 4, following a high-level meeting with the Danish Ambassador to Kenya, Stephan Schønemann. The project is being implemented with support from the Danish government, and cBrain is proud to contribute its technology to this strategic collaboration. According to the Cabinet Secretary, the new digital platform will be fundamental in reinforcing transparency and accountability...

Grundet lokale børslukkedage i de underliggende markeder vil følgende afdeling i Investeringsforeningen Carnegie Wealth Management være suspenderet i dag fredag den 6. juni 2025.Afdeling LEI-kode ISIN-kode OMX Shortname  Nordiske Aktier 549300822ZTGB1F0PU21 DK0061136058 CMINOA                             Eventuelle henvendelser vedrørende denne meddelelse kan rettes til undertegnede på telefon 3814 6600. Med venlig hilsen Invest Administration A/S Niels Erik EberhardDirektør

Fixed Income Investor Meetings  06 June 2025  BW Energy has engaged Pareto Securities as Global Coordinator together with Arctic Securities as Joint Bookrunners to arrange a series of fixed income investor meetings. Fearnley Securities and Sparebank1 Markets are acting as Co-Managers. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue of USD 300 million with a tenor of five years may follow. The purpose of the bond issue is for general corporate purposes. Holders of BWE01 bonds will be offered to roll-over their bonds into the new contemplated bond issue.  BW Group (76.5% shareholder and primary insider through Mr. Andreas Sohmen-Pao) has the intention to subscribe and be allocated USD 100 million in the new bond including roll-over of USD  38.5 million of their existing BWE01 bonds. CEO Carl...

Press ReleaseNicox: Notice of the Ordinary and Extraordinary Shareholders’ Meeting on June 27, 2025 and appointment of an ad hoc representativeJune 6, 2025 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, reminds its shareholders that the Ordinary and Extraordinary General Meeting will be held on Friday, June 27, 2025 at 2:30 p.m., at the Company’s headquarters located at Sundesk Sophia Antipolis, rue Evariste Galois, Emerald Square, Bâtiment C – 06410 Biot. The agenda and the text of the draft resolutions proposed to the Ordinary and Extraordinary Shareholders’ Meeting are included in the notice of meeting published in the Bulletin des Annonces Légales Obligatoires (Official Bulletin of Mandatory Legal Announcements) No. 61 dated...